29 research outputs found

    Structure and Dynamics of Thermosensitive pDNA Polyplexes Studied by Time-Resolved Fluorescence Spectroscopy

    Get PDF
    Combining multiple stimuli-responsive functionalities into the polymer design is an attractive approach to improve nucleic acid delivery. However, more in-depth fundamental understanding how the multiple functionalities in the polymer structures are influencing polyplex formation and stability is essential for the rational development of such delivery systems. Therefore, in this study the structure and dynamics of thermosensitive polyplexes were investigated by tracking the behavior of labeled plasmid DNA (pDNA) and polymer with time-resolved fluorescence spectroscopy using fluorescence resonance energy transfer (FRET). The successful synthesis of a heterofunctional poly(ethylene glycol) (PEG) macroinitiator containing both an atom transfer radical polymerization (ATRP) and reversible addition-fragmentation chain-transfer (RAFT) initiator is reported. The use of this novel PEG macroinitiator allows for the controlled polymerization of cationic and thermosensitive linear triblock copolymers and labeling of the chain-end with a fluorescent dye by maleimide-thiol chemistry. The polymers consisted of a thermosensitive poly(N-isopropylacrylamide) (PNIPAM, N), hydrophilic PEG (P), and cationic poly(2-(dimethylamino)ethyl methacrylate) (PDMAEMA, D) block, further referred to as NPD. Polymer block D chain-ends were labeled with Cy3, while pDNA was labeled with FITC. The thermosensitive NPD polymers were used to prepare pDNA polyplexes, and the effect of the N/P charge ratio, temperature, and composition of the triblock copolymer on the polyplex properties were investigated, taking nonthermosensitive PD polymers as the control. FRET was observed both at 4 and 37 degrees C, indicating that the introduction of the thermosensitive PNIPAM block did not compromise the polyplex structure even above the polymer's cloud point. Furthermore, FRET results showed that the NPD- and PD-based polyplexes have a less dense core compared to polyplexes based on cationic homopolymers (such as PEI) as reported before. The polyplexes showed to have a dynamic character meaning that the polymer chains can exchange between the polyplex core and shell. Mobility of the polymers allow their uniform redistribution within the polyplex and this feature has been reported to be favorable in the context of pDNA release and subsequent improved transfection efficiency, compared to nondynamic formulations.Peer reviewe

    Π‘Ρ‚Π°Ρ‚Π΅Π²Ρ– особливості ΠΌΠ΅Ρ‚Π°Π±ΠΎΠ»Ρ–Π·ΠΌΡƒ ΠΌΡ–ΠΎΠΊΠ°Ρ€Π΄Π° Π² Π΄ΠΈΠ½Π°ΠΌΡ–Ρ†Ρ– Ρ€ΠΎΠ·Π²ΠΈΡ‚ΠΊΡƒ Π΅ΠΊΡΠΏΠ΅Ρ€ΠΈΠΌΠ΅Π½Ρ‚Π°Π»ΡŒΠ½ΠΎΠ³ΠΎ Π³Ρ–ΠΏΠ΅Ρ€Ρ‚ΠΈΡ€Π΅ΠΎΠ·Ρƒ

    Get PDF
    Π’ экспСримСнтах Π½Π° ΠΏΠΎΠ»ΠΎΠ²ΠΎΠ·Ρ€Π΅Π»Ρ‹Ρ… самцах ΠΈ самках крыс исслСдовано Π°ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ пСрСкисного окислСння Π»ΠΈΠΏΠΈΠ΄ΠΎΠ², антиоксидантной Π·Π°Ρ‰ΠΈΡ‚Ρ‹ ΠΈ энСргообразования Π² Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠ΅ развития тироксиновой ΠΊΠ°Ρ€Π΄ΠΈΠΎΠΌΠΈΠΎΠΏΠ°Ρ‚ΠΈΠΈ, ΠΊΠΎΡ‚ΠΎΡ€ΡƒΡŽ ΠΌΠΎΠ΄Π΅Π»ΠΈΡ€ΠΎΠ²Π°Π»ΠΈ Π²Π²Π΅Π΄Π΅Π½ΠΈΠ΅ΠΌ L-тироксина (500 ΠΌΠ³/ΠΊΠ³, Π²Π½ΡƒΡ‚Ρ€ΠΈΠΆΠ΅Π»ΡƒΠ΄ΠΎΡ‡Π½ΠΎ, Π΅ΠΆΠ΅Π΄Π½Π΅Π²Π½ΠΎ). Π’ ΠΌΠΈΠΎΠΊΠ°Ρ€Π΄Π΅ ΠΆΠ΅Π»ΡƒΠ΄ΠΎΡ‡ΠΊΠΎΠ² Ρ‡Π΅Ρ€Π΅Π· 5, 10 ΠΈ 15 Π΄Π½Π΅ΠΉ с Π½Π°Ρ‡Π°Π»Π° экспСримСнта опрСдСляли содСрТаниС Π΄ΠΈΠ΅Π½ΠΎΠ²Ρ‹Ρ… ΠΈ Ρ‚Ρ€ΠΈΠ΅Π½ΠΎΠ²Ρ‹Ρ… ΠΊΠΎΠ½ΡŒΡŽΠ³Π°Ρ‚ (Π”Πš, ВК), Π’Π‘Πš-Π°ΠΊΡ‚ΠΈΠ²Π½Ρ‹Ρ… ΠΏΡ€ΠΎΠ΄ΡƒΠΊΡ‚ΠΎΠ² (Π’Π‘Πš-АП), Π°ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ супСроксиддисмутазы (Π‘ΠžΠ”), ΠΊΠ°Ρ‚Π°Π»Π°Π·Ρ‹, глутатионпСроксидазы (Π“ΠŸ) ΠΈ Π³Π»ΡƒΡ‚Π°Ρ‚ΠΈΠΎΠ½Ρ€Π΅Π΄ΡƒΠΊΡ‚Π°Π·Ρ‹ (Π“Π ), сукцинатдСгидрогСназы (Π‘Π”Π“), цитохромоксидазы (ЦО). Установили, Ρ‡Ρ‚ΠΎ гипСртироксинСмия Π²ΠΈΠ·Ρ‹Π²Π°Π»Π° Π½Π°ΠΊΠΎΠΏΠ»Π΅Π½ΠΈΠ΅ Π² ΠΌΠΈΠΎΠΊΠ°Ρ€Π΄Π΅ ΠΆΠ΅Π»ΡƒΠ΄ΠΎΡ‡ΠΊΠΎΠ² крыс Π”Πš, ВК ΠΈ Π’Π‘Πš-АП, Ρ‡Ρ‚ΠΎ Π² самок Π±Ρ‹Π»ΠΎ Π±ΠΎΠ»Π΅Π΅ сущСствСнным, Ρ‡Π΅ΠΌ Ρƒ самцов, нСсмотря Π½Π° Π±ΠΎΠ»ΡŒΡˆΡƒΡŽ Π°ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ Π“ΠŸ Ρ‚Π° Π“Π . НСдостаточная протСкторная ΡΡ„Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ Ρ„Π΅Ρ€ΠΌΠ΅Π½Ρ‚ΠΎΠ² систСмы Π³Π»ΡƒΡ‚Π°Ρ‚ΠΈΠΎΠ½Π° Π±Ρ‹Π»Π° Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚ΠΎΠΌ Π·Π½Π°Ρ‡ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠ³ΠΎ угнСтСния активности Π‘ΠžΠ” ΠΈ ΠΊΠ°Ρ‚Π°Π»Π°Π·Ρ‹, Ρ‡Ρ‚ΠΎ ΡΠ²ΠΈΠ΄Π΅Ρ‚Π΅Π»ΡŒΡΡ‚Π²ΠΎΠ²Π°Π»ΠΎ ΠΎ сущСствСнном Π½Π°ΠΊΠΎΠΏΠ»Π΅Π½ΠΈΠΈ Π°ΠΊΡ‚ΠΈΠ²Π½Ρ‹Ρ… Ρ„ΠΎΡ€ΠΌ кислорода. ΠΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ энСргообразования Π² Ρ‚Π°ΠΊΠΈΡ… условиях ΡƒΠΌΠ΅Π½ΡŒΡˆΠ°Π»Π°ΡΡŒ, ΠΎ Ρ‡Π΅ΠΌ ΡΠ²ΠΈΠ΄Π΅Ρ‚Π΅Π»ΡŒΡΡ‚Π²ΠΎΠ²Π°Π»ΠΎ ΡƒΠ³Π½Π΅Ρ‚Π΅Π½ΠΈΠ΅ активности Π‘Π”Π“, ΠΊΠΎΡ‚ΠΎΡ€ΠΎΠ΅ Π±Ρ‹Π»ΠΎ Π°Π½Π°Π»ΠΎΠ³ΠΈΡ‡Π½Ρ‹ΠΌ Π² самцов ΠΈ самок, ΠΈ ЦО, Ρ‡Ρ‚ΠΎ Π±Ρ‹Π»ΠΎ Π±ΠΎΠ»Π΅Π΅ сущСствСнным Π² самок. ΠŸΠΎΠ»ΡƒΡ‡Π΅Π½Π½Ρ‹Π΅ Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹ ΡΠ²ΠΈΠ΄Π΅Ρ‚Π΅Π»ΡŒΡΡ‚Π²ΡƒΡŽΡ‚ ΠΎ Ρ‚ΠΎΠΌ, Ρ‡Ρ‚ΠΎ Ρ€Π°Π·Π²ΠΈΡ‚ΠΈΠ΅ тироксиновой ΠΊΠ°Ρ€Π΄ΠΈΠΎΠΌΠΈΠΎΠΏΠ°Ρ‚ΠΈΠΈ Π²Ρ‹Π·Ρ‹Π²Π°Π΅Ρ‚ сущСствСнный мСтаболичСский дисбаланс Π² ΠΌΠΈΠΎΠΊΠ°Ρ€Π΄Π΅ ΠΆΠ΅Π»ΡƒΠ΄ΠΎΡ‡ΠΊΠΎΠ² самок крыс, Ρ‡Ρ‚ΠΎ Ρ€Π°Π·Ρ€Π΅ΡˆΠ°Π΅Ρ‚ ΠΎΠΆΠΈΠ΄Π°Ρ‚ΡŒ Π±ΠΎΠ»Π΅ΠΌ интСнсивныС структурныС Π½Π°Ρ€ΡƒΡˆΠ΅Π½ΠΈΡ.Lipid peroxidation, antioxidant protection and energy production were studied in adult male and female rats with thyroxin cardiomyopathy, which simulated by introduction of L-thyroxine (500 mg / kg, intraperitoneally, daily). In the myocardium of the ventricles after 5, 10 and 15 days from the start of the experiment determined the content of diene and triene conjugate (DC, TC), TBA-active metabolits (TBA-am), activity of superoxide dismutase (SOD), catalase, glutathione peroxidase (GP) and glutathione reductase (GR), succinate dehydrogenase (SDH), cytochrome oxidase (CO). Found that hyperthyroxinemia caused accumulation in myocardium of the ventricles DC, TC and TBA-am mostly in females despite the higher activity of GP and GR. Lack of protective effects of glutathione system enzymes resulted from significant inhibition of SOD and catalase, indicating a significant accumulation of reactive species of oxygen. Activity of the energy production in these conditions decreased. That was proved by the inhibition of SDH in myocardium both sex animals and CO mostly in females. We conclude that the development of thyroxin cardiomyopathy causes metabolic disbalance in myocardium of the ventricles mostly in female rats, which can results in more intense structural damage

    Three-dimensional cathodoluminescence imaging and electron backscatter diffraction: tools for studying the genetic nature of diamond inclusions

    Get PDF
    As a step towards resolving the genesis of inclusions in diamonds, a new technique is presented. This technique combines cathodoluminescence (CL) and electron backscatter diffraction (EBSD) using a focused ion beam-scanning electron microscope (FIB-SEM) instrument with the aim of determining, in detail, the three-dimensional diamond zonation adjacent to a diamond inclusion. EBSD reveals that mineral inclusions in a single diamond have similar crystallographic orientations to the host, within Β±0. 4Β°. The chromite inclusions record a systematic change in Mg# and Cr# from core to the rim of the diamond that corresponds with a ~80Β°C decrease of their formation temperature as established by zinc thermometry. A chromite inclusion, positioned adjacent to a boundary between two major diamond growth zones, is multi-faceted with preferred octahedral and cubic faces. The chromite is surrounded by a volume of non-luminescent diamond (CL halo) that partially obscures any diamond growth structures. The CL halo has apparent crystallographic morphology with symmetrically oriented pointed features. The CL halo is enriched in ~200 ppm Cr and ~80 ppm Fe and is interpreted to have a secondary origin as it overprints a major primary diamond growth structure. The diamond zonation adjacent to the chromite is complex and records both syngenetic and protogenetic features based on current inclusion entrapment models. In this specific case, a syngenetic origin is favoured with the complex form of the inclusion and growth layers indicating changes of growth rates at the diamond-chromite interface. Combined EBSD and 3D-CL imaging appears an extremely useful tool in resolving the ongoing discussion about the timing of inclusion growth and the significance of diamond inclusion studies. Β© 2010 The Author(s)

    Landbouwgrond met hoge natuurwaarden in Nederland op de kaart

    No full text
    In dit onderzoek is bepaald hoe landbouwgrond met hoge natuurwaarden, ofwel High Nature Value (HNV) landbouwgebieden, in Nederland precies begrensd kan worden, wat de omvang is en wat de belangrijkste kenmerken zijn. In EU-verband is het voorts mogelijk cofinanciering te verkrijgen voor HNV-gebieden binnen POP verband. Gebleken is dat HNV gebieden in Nederland ongeveer tussen de 15% en 20% van het landbouwareaal kunnen beslaan. HNV gebieden liggen vooral in de provincies Drenthe, Friesland en Noord- en Zuid-Holland. Ze overlappen vooral met de nattige maar kleinschalige veenweidegebieden die belangrijk zijn voor broedvogels en overwinteraars, maar ook met de meer open nattere graslanden en akkerbouwgebieden die een belangrijke functie hebben voor overwinterende ganzen en smienten en de meer kleinschalige agrarische landschappen waar specifieke zeldzamere vogel- en vegetatiesoorten voorkomen

    PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time

    No full text
    Extracellular vesicles (EVs) are increasingly being recognized as candidate drug delivery systems due to their ability to functionally transfer biological cargo between cells. However, the therapeutic applicability of EVs may be limited due to a lack of cell-targeting specificity and rapid clearance of exogenous EVs from the circulation. In order to improve EV characteristics for drug delivery to tumor cells, we have developed a novel method for decorating EVs with targeting ligands conjugated to polyethylene glycol (PEG). Nanobodies specific for the epidermal growth factor receptor (EGFR) were conjugated to phospholipid (DMPE)-PEG derivatives to prepare nanobody-PEG-micelles. When micelles were mixed with EVs derived from Neuro2A cells or platelets, a temperature-dependent transfer of nanobody-PEG-lipids to the EV membranes was observed, indicative of a 'post-insertion' mechanism. This process did not affect EV morphology, size distribution, or protein composition. After introduction of PEG-conjugated control nanobodies to EVs, cellular binding was compromised due to the shielding properties of PEG. However, specific binding to EGFR-overexpressing tumor cells was dramatically increased when EGFR-specific nanobodies were employed. Moreover, whereas unmodified EVs were rapidly cleared from the circulation within 10 min after intravenous injection in mice, EVs modified with nanobody-PEG-lipids were still detectable in plasma for longer than 60 min post-injection. In conclusion, we propose post-insertion as a novel technique to confer targeting capacity to isolated EVs, circumventing the requirement to modify EV-secreting cells. Importantly, insertion of ligand-conjugated PEG-derivatized phospholipids in EV membranes equips EVs with improved cell specificity and prolonged circulation times, potentially increasing EV accumulation in targeted tissues and improving cargo delivery

    PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time

    No full text
    Extracellular vesicles (EVs) are increasingly being recognized as candidate drug delivery systems due to their ability to functionally transfer biological cargo between cells. However, the therapeutic applicability of EVs may be limited due to a lack of cell-targeting specificity and rapid clearance of exogenous EVs from the circulation. In order to improve EV characteristics for drug delivery to tumor cells, we have developed a novel method for decorating EVs with targeting ligands conjugated to polyethylene glycol (PEG). Nanobodies specific for the epidermal growth factor receptor (EGFR) were conjugated to phospholipid (DMPE)-PEG derivatives to prepare nanobody-PEG-micelles. When micelles were mixed with EVs derived from Neuro2A cells or platelets, a temperature-dependent transfer of nanobody-PEG-lipids to the EV membranes was observed, indicative of a 'post-insertion' mechanism. This process did not affect EV morphology, size distribution, or protein composition. After introduction of PEG-conjugated control nanobodies to EVs, cellular binding was compromised due to the shielding properties of PEG. However, specific binding to EGFR-overexpressing tumor cells was dramatically increased when EGFR-specific nanobodies were employed. Moreover, whereas unmodified EVs were rapidly cleared from the circulation within 10 min after intravenous injection in mice, EVs modified with nanobody-PEG-lipids were still detectable in plasma for longer than 60 min post-injection. In conclusion, we propose post-insertion as a novel technique to confer targeting capacity to isolated EVs, circumventing the requirement to modify EV-secreting cells. Importantly, insertion of ligand-conjugated PEG-derivatized phospholipids in EV membranes equips EVs with improved cell specificity and prolonged circulation times, potentially increasing EV accumulation in targeted tissues and improving cargo delivery

    PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time

    No full text
    Extracellular vesicles (EVs) are increasingly being recognized as candidate drug delivery systems due to their ability to functionally transfer biological cargo between cells. However, the therapeutic applicability of EVs may be limited due to a lack of cell-targeting specificity and rapid clearance of exogenous EVs from the circulation. In order to improve EV characteristics for drug delivery to tumor cells, we have developed a novel method for decorating EVs with targeting ligands conjugated to polyethylene glycol (PEG). Nanobodies specific for the epidermal growth factor receptor (EGFR) were conjugated to phospholipid (DMPE)-PEG derivatives to prepare nanobody-PEG-micelles. When micelles were mixed with EVs derived from Neuro2A cells or platelets, a temperature-dependent transfer of nanobody-PEG-lipids to the EV membranes was observed, indicative of a 'post-insertion' mechanism. This process did not affect EV morphology, size distribution, or protein composition. After introduction of PEG-conjugated control nanobodies to EVs, cellular binding was compromised due to the shielding properties of PEG. However, specific binding to EGFR-overexpressing tumor cells was dramatically increased when EGFR-specific nanobodies were employed. Moreover, whereas unmodified EVs were rapidly cleared from the circulation within 10 min after intravenous injection in mice, EVs modified with nanobody-PEG-lipids were still detectable in plasma for longer than 60 min post-injection. In conclusion, we propose post-insertion as a novel technique to confer targeting capacity to isolated EVs, circumventing the requirement to modify EV-secreting cells. Importantly, insertion of ligand-conjugated PEG-derivatized phospholipids in EV membranes equips EVs with improved cell specificity and prolonged circulation times, potentially increasing EV accumulation in targeted tissues and improving cargo delivery
    corecore